Published on in Vol 9 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/77621, first published .
Measuring FVIII Activity and Thrombin Generation Simultaneously With a Novel Point of Care Platform (EnzySystem HemA): Qualitative Usability Evaluation

Measuring FVIII Activity and Thrombin Generation Simultaneously With a Novel Point of Care Platform (EnzySystem HemA): Qualitative Usability Evaluation

Measuring FVIII Activity and Thrombin Generation Simultaneously With a Novel Point of Care Platform (EnzySystem HemA): Qualitative Usability Evaluation

Aernoud Bavinck   1, 2 , MD ;   Saskia E M Schols   1, 3 , MD, PhD ;   Wilfred Teunissen   4 , MSc ;   Amy Shapiro   5 , MD ;   Nicole M A Blijlevens   1 , MD, PhD ;   Kyle Davis   5 , MD ;   Waander van Heerde   2, 3 , PhD

1 Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands

2 Enzyre, Nijmegen, The Netherlands

3 Hemophilia Treatment Centre Nijmegen-Eindhoven-Maastricht, Nijmegen, The Netherlands

4 Panton, Deventer, The Netherlands

5 Department of Pediatric Hematology, Innovative Hematology, Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, United States

Corresponding Author: